[Prognosis of XXXX in the adult: influence of treatment].

@entity1 @entity8 @entity548 @entity177 @entity281 @entity17145 @entity810 @entity1985 @entity715 @entity631
The medical histories of 27 @entity1 with @entity715 were evaluated retrospectively. Short and long term evolution as well as prognostic factors were analysed. 24 of the @entity1 were suffering from a @entity1985 , 15 from @entity177 . In the 20 biopsies performed we observed: 14 cases of extramembranous @entity631 , 2 cases of minimal @entity8 , 3 cases of @entity17145 . The @entity715 was bilateral (18), left (7) or right (2). In 7 @entity1 this was associated with @entity715 of the inferior vena cava. 9 @entity1 were treated with anticoagulants alone, 9 underwent thrombectomy, 7 were treated by thrombolysis and 2 received no treatment. Within the first six months 11 @entity1 died as a result of complications due to @entity548 (5), @entity281 (1) and 3 @entity1 died of undetermined causes. The progression of the remaining @entity1 was followed up over a period of 6 months to 19 years. In 12 @entity1 , the @entity1985 regressed and renal function did not deteriorate in any of the cases. The main causes for poor prognosis are the existence of @entity177 and @entity631 which is not extramembranous. Since the evolution of the @entity8 does not appear to be affected by extramembranous @entity631 , @entity715 associated with this complication should be treated with anticoagulants alone. The risk-benefit ratio of thrombectomy leads us to conclude that this technique should be abandoned. Thrombolysis could be considered in cases where @entity715 is associated with @entity810 .
